The NeuroGraft Project 'Development of Functionalised Cell Seeded Bio-artificial Organ for Transplantation in Nerve Repair' (HEALTH-F4-2012-304936) is a collaborative project funded under the 7th EU Framework Program in the health space. As part of this development research project, a free seminar has been organised on general as well as focused topics in regards to CE Marking and the regulatory elements that need to be considered when developing Medical Devices that involve a acombination of advanced materials and biomolecules. The sessions will be held by internationally recognised experts involved in the NeuroGraft project.
Prof. Dr. Ivan Martin, following his PhD in Biomedical Engineering at the University of Genova and a postdoctoral training at Harvard/MIT, established in 1999 a Research Group at the University Hospital of Basel. His team includes scientists from the biological, engineering and clinical fields, promoting interdisciplinary, translational work. His research interests are related to mesenchymal cell differentiation and design/implementation of tissue culture bioreactors for automated and controlled manufacturing of cartilage, bone and osteochondral grafts, based on autologous cells and 3D porous scaffolds. He was president of the European section of the Tissue Engineering Regenerative Medicine International Society (TERMIS) and is currently member of the editorial boards of 5 journals. The developed science and technology of the research group have been translated into three clinical trials for cell-based cartilage and bone repair, and into the founding of a spin-out company for the commercialization of tissue culture bioreactors (Cellec Biotek AG).